A randomized multicenter non-inferiority phase III trial of chemoradiotherapy and local excision versus total mesorectal excision in T2–T3ab,N0,M0 rectal cancer (the TAUTEM study)

Name: A randomized multicenter non-inferiority phase III trial of chemoradiotherapy and local excision versus total mesorectal excision in T2–T3ab,N0,M0 rectal cancer (the TAUTEM study)
Creator: CORA.Repositori de Dades de Recerca
Published: 2025-06-10 23:18:53
License: 暂无描述

DataCite Commons2025-06-10 更新2024-07-13 收录

下载链接：

https://dataverse.csuc.cat/citation?persistentId=doi:10.34810/data1181

下载链接

链接失效反馈

官方服务：

资源简介：

According to international guidelines, the standard treatment of stage T2-T3ab,N0,M0 rectal cancer is total mesorectal excision (TME). The TAUTEM study is a multicenter phase III trial designed to assess an alternative treatment that preserves the rectum applying oncological non-inferiority criteria

提供机构：

CORA.Repositori de Dades de Recerca

创建时间：

2024-03-20

​​A randomized multicenter non-inferiority phase III trial of chemoradiotherapy and local excision versus total mesorectal excision in T2–T3ab,N0,M0 rectal cancer (the TAUTEM study)​

A randomized multicenter non-inferiority phase III trial of chemoradiotherapy and local excision versus total mesorectal excision in T2–T3ab,N0,M0 rectal cancer (the TAUTEM study)